AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 95 filers reported holding AKERO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,686 | +32.9% | 33,331 | +22.7% | 0.00% | 0.0% |
| Q2 2023 | $1,269 | +19.8% | 27,172 | -1.8% | 0.00% | +100.0% |
| Q1 2023 | $1,059 | -40.8% | 27,682 | -15.2% | 0.00% | -50.0% |
| Q4 2022 | $1,788 | -99.7% | 32,629 | +61.2% | 0.00% | +100.0% |
| Q3 2022 | $689,000 | +300.6% | 20,237 | +11.3% | 0.00% | – |
| Q2 2022 | $172,000 | -33.6% | 18,182 | -0.2% | 0.00% | – |
| Q1 2022 | $259,000 | -32.7% | 18,222 | +0.1% | 0.00% | – |
| Q4 2021 | $385,000 | -5.6% | 18,197 | -0.4% | 0.00% | – |
| Q3 2021 | $408,000 | -25.5% | 18,266 | -17.4% | 0.00% | -100.0% |
| Q2 2021 | $548,000 | +40.9% | 22,104 | +65.0% | 0.00% | – |
| Q1 2021 | $389,000 | +12.4% | 13,400 | 0.0% | 0.00% | – |
| Q4 2020 | $346,000 | +11.3% | 13,400 | +32.7% | 0.00% | – |
| Q3 2020 | $311,000 | +23.4% | 10,100 | 0.0% | 0.00% | – |
| Q2 2020 | $252,000 | +125.0% | 10,100 | +90.6% | 0.00% | – |
| Q1 2020 | $112,000 | -5.1% | 5,300 | 0.0% | 0.00% | – |
| Q4 2019 | $118,000 | -2.5% | 5,300 | 0.0% | 0.00% | – |
| Q3 2019 | $121,000 | – | 5,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Skorpios Trust | 3,271,829 | $125,180,178 | 50.58% |
| COMMODORE CAPITAL LP | 790,000 | $30,225,400 | 4.60% |
| Redmile Group, LLC | 2,044,389 | $78,218,323 | 3.39% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 202,561 | $7,749,984 | 3.20% |
| Ghost Tree Capital, LLC | 275,000 | $10,522,000 | 3.11% |
| Avidity Partners Management LP | 2,447,000 | $93,622,220 | 3.11% |
| Atlas Venture Life Science Advisors, LLC | 594,251 | $22,736,043 | 3.08% |
| Logos Global Management LP | 400,000 | $15,304,000 | 2.19% |
| Yiheng Capital Management, L.P. | 1,125,791 | $43,072,764 | 1.70% |
| Boxer Capital, LLC | 831,495 | $31,813 | 1.56% |